Sernova Corp (SVA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sernova Corp (SVA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7125
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from immune system. The company’s product portfolio addresses metabolic diseases such as insulin dependent diabetes and thyroid disease; and blood disorders such as hemophilia A; and other neurological ailments. Sernova is headquartered in London, Ontario, Canada.

Sernova Corp (SVA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sernova Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sernova Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sernova Corp, Medical Equipment, Deal Details 10
Equity Offering 10
Sernova Raises USD1.7 Million in Second and Final Tranche of Private Placement of Units 10
Sernova Raises USD1.6 Million in First Tranche of Private Placement of Units 12
Sernova Completes Private Placement Of Units For US$2 Million 13
Sernova Completes Second Tranche Of Private Placement Of Units For US$0.14 Million 14
Sernova Corp – Key Competitors 15
Sernova Corp – Key Employees 16
Sernova Corp – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
May 04, 2018: Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer 18
Government and Public Interest 20
Jun 05, 2017: Sernova Provides Company Outlook on Corporate and Clinical Developments 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Sernova Corp, Medical Equipment, Key Facts, 2017 2
Sernova Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sernova Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Deals By Market, 2012 to YTD 2018 8
Sernova Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sernova Raises USD1.7 Million in Second and Final Tranche of Private Placement of Units 10
Sernova Raises USD1.6 Million in First Tranche of Private Placement of Units 12
Sernova Completes Private Placement Of Units For US$2 Million 13
Sernova Completes Second Tranche Of Private Placement Of Units For US$0.14 Million 14
Sernova Corp, Key Competitors 15
Sernova Corp, Key Employees 16

List of Figures
Sernova Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sernova Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sernova Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sernova Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sernova Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sernova Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sernova Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sernova Corp (SVA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sappi Limited:企業の戦略・SWOT・財務分析
    Sappi Limited - Strategy, SWOT and Corporate Finance Report Summary Sappi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Miele & Cie. KG:企業の戦略的SWOT分析
    Miele & Cie. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • Sun Resources NL (SUR):企業の財務・戦略的SWOT分析
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • Elos Medtech AB (ELOS B):医療機器:M&Aディール及び事業提携情報
    Summary Elos Medtech AB (Elos Medtech) is a partner in development and manufacturer of medical devices and components. The company’s products include dental and orthopedic implants and instruments. It offers diagnostic devices used in the treatment of diabetes, neurosurgery, heart surgery and hearin …
  • Fortis Inc (FTS):企業の財務・戦略的SWOT分析
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • Ritter Pharmaceuticals Inc (RTTR):製薬・医療:M&Aディール及び事業提携情報
    Summary Ritter Pharmaceuticals Inc (Ritter) is a developer of therapeutic products for gastrointestinal diseases. The company’s lead product includes RP-G28, which is developed stimulate the growth of lactose-metabolizing bacteria in the colon to assist in digesting process. Its product is under the …
  • Genting Plantations Berhad (GENP):企業の財務・戦略的SWOT分析
    Genting Plantations Berhad (GENP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Camlin Fine Sciences Limited:戦略・SWOT・企業財務分析
    Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • I.Ceram SA (ALICR):医療機器:M&Aディール及び事業提携情報
    Summary I.Ceram SA (I.Ceram) is a medical equipment and device company that designs, manufactures, and markets joint implants for neurosurgery and other surgical procedures. The company’s products include bone fillers, alumina bio-ceramic implants, trepan caps, cervical plates and blocks for cervica …
  • Telkom SA SOC Limited:戦略・SWOT・企業財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT PLN (Persero):企業の発電所・SWOT分析2018
    PT PLN (Persero) - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Shanghai Zhenhua Heavy Industry Co Ltd:戦略・SWOT・企業財務分析
    Shanghai Zhenhua Heavy Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Zhenhua Heavy Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Claire’s Stores Inc:企業の戦略・SWOT・財務分析
    Claire's Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Claire's Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Becton Dickinson and Co (BDX)-製薬・医療分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • China National Chemical Engineering Co., Ltd:企業の戦略・SWOT・財務情報
    China National Chemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary China National Chemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Taiyo Nippon Sanso Corp (4091):企業の財務・戦略的SWOT分析
    Taiyo Nippon Sanso Corp (4091) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BioXcel Therapeutics Inc (BTAI):製薬・医療:M&Aディール及び事業提携情報
    Summary BioXcel Therapeutics Inc (BioXcel Therapeutics) a subsidiary of BioXcel Corp is a clinical stage biopharmaceutical company focused on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology. Its pipeline product portfolio includes BXCL501, an ad …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆